Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDSn         Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

首页> 外文期刊>Clinical Infectious Diseases >Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDSn Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

【24h】

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDSn Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

机译：初次治疗的患者每天一次与每天两次联合使用抗逆转录病毒疗法的比较：AIDSn临床试验组（ACTG）A5073（一项为期48周的随机对照试验）的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Infectious Diseases》 |2010年第7期|p.1041-1052|共12页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-18 01:08:30

相似文献

外文文献
中文文献
专利

1. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. [J] . Flexner C, Tierney C, Gross R, Clinical infectious diseases . 2010,第7期

机译：初次治疗的患者每天一次与每天两次联合抗逆转录病毒疗法的比较：AIDS临床试验组（ACTG）A5073的结果，一项为期48周的随机对照试验。
2. Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial. [J] . Eron JJ, Feinberg J, Kessler HA, The Journal of Infectious Diseases . 2004,第2期

机译：初次使用抗逆转录病毒治疗的HIV阳性患者的洛匹那韦/利托那韦每日1次和每日2次：48周随机临床试验。
3. Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status [J] . Andrea Bezjak, Corinne Faivre-Finn, Elena Wilson, BMJ Open . 2016,第1期

机译：CONVERT试验方案-每天一次VErsus每天两次并发放射疗法：一项同时进行放化疗的国际2臂随机对照试验，比较了有限期小细胞肺癌（LS-SCLC）患者每天两次和每天一次放射疗法的时间表）和良好的状态
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 MHz Versus 3 MHz: A Double Blind Randomized Clinical Trial [D] . Kattoof, Alyaa. 2020

机译：超声治疗对双侧肌肉肌痛的影响：1 MHz对3 MHz的比较：双盲随机临床试验
6. COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE PATIENTS: RESULTS OF AIDS CLINICAL TRIALS GROUP (ACTG) A5073 A 48-WEEK RANDOMIZED CONTROLLED TRIAL [O] . Charles Flexner, Camlin Tierney, Robert Gross, -1

机译：初治患者一次一次与两次两次联合抗病毒治疗的比较：艾滋病临床试验组（ACTG）A5073（48周随机对照试验）的结果
7. Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status. [O] . Faivre-Finn, Corinne, Falk, Sally, Ashcroft, Linda, 2016

机译：CONVERT试验方案 - 每日两次并发每日VErsus每日两次放射治疗：一项同步化放疗的国际双臂随机对照试验，比较有限期小细胞肺癌患者的每日两次和每日一次放疗时间表（Ls-sCLC））和良好的性能状态。
8. Studies of Ocular Complications of AIDS (SOCA). Foscarnet- GanciclovirCytomegalovirus Retinitis Trial (FGCRT). AIDS Clinical Trial Group (ACTG) Protocol 129. Antiviral Effects of Foscarnet and Ganciclovir Therapy on HIV p24 Antigen in Patients with AIDS a [R] . 1995

机译：艾滋病眼部并发症（sOCa）的研究。膦甲酸 - 更昔洛韦巨细胞病毒视网膜炎试验（FGCRT）。艾滋病临床试验组（aCTG）议定书129.膦甲酸和更昔洛韦治疗对艾滋病患者HIV p24抗原的抗病毒作用

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDSn Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

著录项

相似文献

相关主题

期刊订阅